Literature DB >> 27042243

Flexible Bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effects.

Thomas A Murray1, Brian P Hobbs1, Daniel J Sargent2, Bradley P Carlin3.   

Abstract

Presently, there are few options with available software to perform a fully Bayesian analysis of time-to-event data wherein the hazard is estimated semi- or non-parametrically. One option is the piecewise exponential model, which requires an often unrealistic assumption that the hazard is piecewise constant over time. The primary aim of this paper is to construct a tractable semiparametric alternative to the piecewise exponential model that assumes the hazard is continuous, and to provide modifiable, user-friendly software that allows the use of these methods in a variety of settings. To accomplish this aim, we use a novel model formulation for the log-hazard based on a low-rank thin plate linear spline that readily facilitates adjustment for covariates with time-dependent and proportional hazards effects, possibly subject to shape restrictions. We investigate the performance of our model choices via simulation. We then analyze colorectal cancer data from a clinical trial comparing the effectiveness of two novel treatment regimes relative to the standard of care for overall survival. We estimate a time-dependent hazard ratio for each novel regime relative to the standard of care while adjusting for the effect of aspartate transaminase, a biomarker of liver function, that is subject to a non-decreasing shape restriction.

Entities:  

Keywords:  Bayesian methods; Colorectal cancer; Penalized splines; Semiparametric methods; Shape-restricted effects; Survival analysis; Time-dependent effects

Year:  2015        PMID: 27042243      PMCID: PMC4811615          DOI: 10.1214/15-BA954

Source DB:  PubMed          Journal:  Bayesian Anal        ISSN: 1931-6690            Impact factor:   3.728


  6 in total

1.  Generating survival times to simulate Cox proportional hazards models.

Authors:  Ralf Bender; Thomas Augustin; Maria Blettner
Journal:  Stat Med       Date:  2005-06-15       Impact factor: 2.373

2.  The BUGS project: Evolution, critique and future directions.

Authors:  David Lunn; David Spiegelhalter; Andrew Thomas; Nicky Best
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

3.  Bayesian analysis of proportional hazards models built from monotone functions.

Authors:  A E Gelfand; B K Mallick
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

4.  A Bayesian proportional hazards model for general interval-censored data.

Authors:  Xiaoyan Lin; Bo Cai; Lianming Wang; Zhigang Zhang
Journal:  Lifetime Data Anal       Date:  2014-08-07       Impact factor: 1.588

5.  A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Authors:  Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
Journal:  J Clin Oncol       Date:  2003-12-09       Impact factor: 44.544

6.  A semiparametric Bayesian proportional hazards model for interval censored data with frailty effects.

Authors:  Volkmar Henschel; Jutta Engel; Dieter Hölzel; Ulrich Mansmann
Journal:  BMC Med Res Methodol       Date:  2009-02-10       Impact factor: 4.615

  6 in total
  2 in total

1.  Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials.

Authors:  Lucie Biard; Anne Bergeron; Vincent Lévy; Sylvie Chevret
Journal:  Contemp Clin Trials Commun       Date:  2021-01-09

2.  Estimating an Individual's Probability of Revision Surgery After Knee Replacement: A Comparison of Modeling Approaches Using a National Data Set.

Authors:  Parham Aram; Lea Trela-Larsen; Adrian Sayers; Andrew F Hills; Ashley W Blom; Eugene V McCloskey; Visakan Kadirkamanathan; Jeremy M Wilkinson
Journal:  Am J Epidemiol       Date:  2018-10-01       Impact factor: 4.897

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.